Drawing for VIVLION

USPTO serial 88024102

VIVLION

Reviewed by CopyMark Law Group

Reg. 5906320Status 701Registered
Filing date
Status date
Registration date
Nov 12, 2019
Examiner
KUMIS, SCOTT N
Law office
Historical data usage

What this means

Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with VIVLION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel A. Grossman

Daniel A. Grossman ZVMLaw PLLC777 East Eisenhower Parkway, Suite 910Ann Arbor, MI 48108United States

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific use; chemical preparations for scientific and research purposes; biological preparations for scientific research purposes; biochemical products for scientific use in vivo and in vitroACTIVE—
005Biological preparations for the treatment of cancer, neurodegeneration, immunologic diseases, cardiovascular diseases, metabolic diseases, infections, mental diseases and respiratory diseases for medical purposes; biochemical preparations for the treatment of cancer, neurodegeneration, immunologic diseases, cardiovascular diseases, metabolic diseases, infections, mental diseases and respiratory diseases for medical purposes; chemical reagents for medical purposes; biotechnological preparations for the treatment of cancer, neurodegeneration, immunologic diseases, cardiovascular diseases, metabolic diseases, infections, mental diseases and respiratory diseases for medical purposes; diagnostic agents, preparations and substances for medical purposes; diagnostic reagents for medical purposes; nucleic acid sequences for medical purposes; pharmaceutical preparations, therapeutic medicines and substances for the treatment of cancer, neurodegeneration, immunologic diseases, cardiovascular diseases, metabolic diseases, infections, mental diseases and respiratory diseases; nucleoside-containing pharmaceutical preparations, namely, antivirals for scientific biomedical purposesACTIVE—
042Research and development services for the pharmaceutical industry; research and development services for the biotechnology sector; scientific research, testing and analysis services in the field of pharmaceuticals; laboratory research services in the field of pharmaceuticals; advisory services relating to technical and scientific analysis of pharmaceuticals; technical and scientific analysis in the field of pharmaceuticals; biomedical research; pharmaceutical research and development; scientific research for medical purposes; scientific research in the nature of analysis of large datasets relating to data connectivity, targeted data search; Provision of information and data relating to medical and veterinary research and development in the field of pharmaceuticals; Provision of information and data relating to scientific and technological research and development in the field of pharmaceuticals; computer aided scientific research analysis; Provision of online scientific information for industrial analysis and research in the field of pharmaceuticals; preparation of biological samples for scientific testing and analysis in research laboratoriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 11, 2026NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Mar 11, 20268.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Mar 9, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 21, 2025ES8RTEAS SECTION 8 RECEIVED—
Nov 12, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 20, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 20, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 20, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 20, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 20, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 20, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 20, 2024EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Sep 20, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 20, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 20, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 29, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 12, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 4, 2019DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Oct 4, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 27, 2019IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 27, 2019D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Aug 26, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 26, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 16, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 15, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 15, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jan 15, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 15, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 15, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 12, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 12, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 12, 2018ALIEASSIGNED TO LIE—
Dec 11, 2018DOCKASSIGNED TO EXAMINER—
Dec 10, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 21, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 21, 2018ALIEASSIGNED TO LIE—
Nov 9, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 24, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 24, 2018DOCKASSIGNED TO EXAMINER—
Jul 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 6, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance